Silvia Ferrati

Silvia Ferrati

Auto-generated profile, based on publicly available information

Silvia Ferrati

College of Pharmacy, The University of Texas at Austin , 2409 West University Avenue, PHR 4.214, Austin, Texas 78712, United States

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ABAshlee Brunaugh
Ashlee Brunaugh
SJSyed Umer Jan
Syed Umer Jan
SFSilvia Ferrati
Silvia Ferrati
Hugh D.C. SmythHugh D.C. Smyth
Hugh D.C. Smyth

22 August 2017 in Biochemistry
Verified
Journal Article
Closed access
AGAvinash K. Gadok
Avinash K. Gadok
CZChi Zhao
Chi Zhao
AMAmanda I. Meriwether
Amanda I. Meriwether
SFSilvia Ferrati
Silvia Ferrati
TRTanner G. Rowley
Tanner G. Rowley
JSJeanne C. Stachowiak
Jeanne C. Stachowiak

2 August 2017 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
SFSilvia Ferrati
Silvia Ferrati
AGAvinash K. Gadok
Avinash K. Gadok
ABAshlee D. Brunaugh
Ashlee D. Brunaugh
CZChi Zhao
Chi Zhao
LHLara A. Heersema
Lara A. Heersema
JSJeanne C. Stachowiak
Jeanne C. Stachowiak
Gap junction (GJ) channels facilitate cell–cell communication through the exchange of chemical and mechanical signals, ensuring proper tissue development and homeostasis. The complex, disease stage-dependent role of connexins in breast cancer progression has been extensively studied over the past two decades. In the early stages of breast cancer, substantial evidence supports the role of GJ channels, formed by connexins at the interfaces between neighbouring cells, as suppressors of cell migration and proliferation. These findings suggest that materials that reintroduce connexins into the tumour cell environment have the potential to inhibit cell migration. Here, we report that exposure of highly metastatic MDA-MB-231 breast tumour cells to connexin-rich biovesicle materials potently suppresses cell migration. Specifically, these biovesicles, which can form GJ interfaces with cells, were extracted from the plasma membrane of donor cells engineered to express a high concentration of functional connexin 43 channels. These connexin-rich membrane materials dramatically reduced cell migration in both a transwell migration assay and a scratch closure assay. Collectively, these results suggest that using membrane materials to reintroduce connexins into the tumour cell environment provides a novel approach for combating cell migration and invasion.